Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Fran Sverdrup

Fran Sverdrup

individual
Ecosystem influencer

About

Fran Sverdrup, Ph.D., is an associate professor of biochemistry and molecular biology at Saint Louis University and a drug-discovery researcher focused on facioscapulohumeral muscular dystrophy, infectious diseases, and epigenetic therapeutics. He directs the Institute for Drug and Biotherapeutic Innovation Discovery Services Core and has worked across academic and pharmaceutical settings on translational biomedical research. SLU reports that his work has generated patents, industry collaboration with Ultragenyx, and more than $6 million in research funding.

Areas of interest

biotechdrug discoveryhuman geneticsinfectious diseasesepigeneticsmuscular dystrophyFSHDtranslational medicinepharmacology